Newsfeeds - Spark Newswire

1 minute read

Zomedica Pharmaceuticals Q4 EPS $(0.01) Beats $(0.01) Estimate, Sales $6.16M Miss $6.20M Estimate

March 15, 5:05 PM

Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.01) by 40 percent. The company reported quarterly sales of $6.16 million which missed

ZOM

1 minute read

Zomedica Pharmaceuticals Q4 Sales $6.20M Inline

By Michael Horton

March 15, 4:49 PM

Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly sales of $6.20 million which met the analyst consensus estimate. This is a 51.92 percent increase over sales of $4.08 million the same period last year.

ZOM

1 minute read

News

Zomdica On January 17 Along With Unit, Zominc And Zomedica Entities Entered Into Three Related Agreements With Qorvo Biotechnologies Including Transition And Support Agreement, BAW Sensor Supply Agreement, Development And Manufacturing License Agreemen…

By Bill Haddad

January 24, 7:12 AM

-Reuters

ZOM

1 minute read

News

Zomedica To Take Control Of Aspects Of TRUFORMA Product Line Previously Provided By Qorvo

By Benzinga Newsdesk

January 18, 7:02 AM

Under the agreements, Zomedica will take control of aspects of the TRUFORMA product line previously provided by Qorvo, including development of new assays and manufacturing both instruments and assay cartridges. This

QRVO

1 minute read

Zomedica Announced Expanded Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors

By Charles Gross

January 17, 7:13 AM

Zomedica Corp. (NYSE American: ZOM) today announced that in cooperation with Structured Monitoring Products, Inc. (SMP), it will begin commercializing the revolutionary VetGuardian® zero-touch vital signs remote monitoring system for veterinary professionals.

ZOM